Global Market Reach Novartis has a widespread presence with products reaching nearly one billion people globally, indicating a strong potential for supply chain, distribution, and logistics partnerships for companies looking to expand their reach in healthcare markets.

Research & Development Expansion Recent investments in new biomedical research facilities and acquisitions of innovative companies like Atrium Therapeutics suggest opportunities to collaborate on cutting-edge therapies and R&D support services, particularly in biotech and personalized medicine.

Facility Growth in US With significant expansion of manufacturing facilities in the United States, including a new radioligand therapy plant in Texas, there are opportunities for local suppliers, equipment providers, and service vendors to engage with Novartis’s production scale-up efforts.

Emphasis on Innovation Novartis’s focus on innovative medicines and digital technologies positions it as a potential partner for tech providers aiming to integrate healthcare solutions, advanced analytics, or digital health platforms into large pharmaceutical ecosystems.

Financial and Legal Challenges Ongoing legal issues related to drug pricing practices may open avenues for consulting, compliance, and legal advisory services, as Novartis seeks to navigate regulatory and reputational risks while maintaining innovative product pipelines.